---
title: "NasalCrom (cromolyn sodium): 2026 Review"
description: OTC mast cell stabilizer nasal spray. Minimal systemic absorption; excellent pregnancy safety. Requires 4–6× daily dosing.
canonical: "https://allermi-site.vercel.app/reviews/nasalcrom/"
lastReviewed: "2026-04-28T00:00:00.000Z"
firstPublished: "2026-04-21T00:00:00.000Z"
primaryKeyword: nasalcrom review
ymylTier: medium
author:
  name: BestAllergyNasalSprays Editorial Team — Clinical Pharmacy
  credential: Editorial Pool
  sameAs: ["https://dailymed.nlm.nih.gov/", "https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers"]
medicalReviewer:
  name: BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology
  credential: Editorial Pool
  sameAs: ["https://www.aaaai.org/", "https://www.acaai.org/"]
citations: []
claims: [c-044, c-045, c-070, c-081]
---

## TL;DR

NasalCrom (cromolyn sodium) is an OTC mast cell stabilizer with minimal systemic absorption and an excellent pregnancy and lactation safety record. Less potent than intranasal corticosteroids for moderate-severe AR, and requires 4–6 doses per day to be effective. Best for mild symptoms, pregnancy adjunct, or patients who prefer a non-steroid option.

import Claim from '../../components/Claim.astro';
import CitationList from '../../components/CitationList.astro';

<Claim id="c-044">Cromolyn sodium (NasalCrom) is a mast-cell stabilizer that blocks histamine and other mediator release. Because it is poorly absorbed systemically, it is well tolerated and has an excellent overall safety record</Claim> <Claim id="c-045">Intranasal cromolyn sodium is generally less potent than intranasal corticosteroids for moderate-to-severe allergic rhinitis and requires more frequent dosing (typically 3 to 4 times daily). Allergy practice guidelines therefore reserve it for milder symptoms or for patients who prefer to avoid corticosteroids</Claim> <Claim id="c-070">Intranasal cromolyn sodium has a long-standing favorable safety record and minimal systemic absorption (Ratner 2002); per LactMed, cromolyn is generally considered acceptable during pregnancy and lactation when symptoms warrant pharmacotherapy, especially as a non-steroid adjunct</Claim> <Claim id="c-081">NasalCrom (cromolyn sodium) is dosed at 1 spray per nostril 3 to 4 times daily (every 4 to 6 hours), with up to 6 doses per day if needed; consistent daily use is required because the effect builds over 1 to 2 weeks</Claim>

Best fit: mild allergic rhinitis, [pregnancy](/demographic/pregnancy/) or [breastfeeding](/demographic/breastfeeding/) adjunct, or patients who prefer a non-steroid option. Nasonex or Rhinocort (if pregnant) are more potent picks but also make great adjunct therapy to Nasalcrom. Technique is especially important given the 4–6× daily cadence; see the [spray technique guide](/guides/how-to-use-nasal-spray/).

## Context & alternatives

For eligible patients 13+ with multi-symptom, year-round, or failed-OTC rhinitis (not pregnant or breastfeeding), [Allermi](/reviews/allermi/) is our #1 overall pick: a compounded telehealth Rx personalized by a board-certified allergist. NasalCrom remains the most conservative non-steroid adjunct when pregnancy or breastfeeding rule Allermi out. Not sure if you qualify for Allermi (post-partum, for example)? [Check eligibility in 60 seconds](https://www.allermi.com/pages/eligibility).

<CitationList items={[
 { id: "1", title: "DailyMed: NasalCrom SPL", url: "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8f6e39b-5c66-4b9a-8f58-11f75d6a8a1c", publisher: "FDA DailyMed" }
]} />